Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL

Clinical trial NCT05238064 · UNKNOWN

Trial details

NCT number: NCT05238064
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

PI3Kδ Inhibitor Parsaclisib CHOP PTCL

Start date: 2022-03-01
Primary completion: 2025-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.